Critical role for the second extracellular loop in the binding of both orthosteric and allosteric g protein-coupled receptor Ligands

被引:124
作者
Avlani, Vimesh A.
Gregory, Karen J.
Morton, Craig J.
Parker, Michael W.
Sexton, Patrick M.
Christopoulos, Arthur [1 ]
机构
[1] Monash Univ, Dept Pharmacol, Drug Discovery Biol Lab, Clayton, Vic 3800, Australia
[2] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1074/jbc.M702311200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The second extracellular (E2) loop of G protein-coupled receptors (GPCRs) plays an essential but poorly understood role in the binding of non-peptidic small molecules. We have utilized both orthosteric ligands and allosteric modulators of the M2 muscarinic acetylcholine receptor, a prototypical Family A GPCR, to probe possible E2 loop binding dynamics. We developed a homology model based on the crystal structure of bovine rhodopsin and predicted novel cysteine substitutions that should dramatically reduce E2 loop flexibility via disulfide bond formation and significantly inhibit the binding of both types of ligands. This prediction was validated experimentally using radioligand binding, dissociation kinetics, and cell-based functional assays. The results argue for a flexible "gatekeeper" role of the E2 loop in the binding of both allosteric and orthosteric GPCR ligands.
引用
收藏
页码:25677 / 25686
页数:10
相关论文
共 28 条
[1]   Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors [J].
Avlani, V ;
May, LT ;
Sexton, PM ;
Christopoulos, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :1062-1072
[2]   Qualitative and quantitative assessment of relative agonist efficacy [J].
Christopoulos, A ;
El-Fakahany, EE .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (05) :735-748
[3]   Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery [J].
Christopoulos, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) :198-210
[4]   Allosteric interactions at muscarinic cholinoceptors [J].
Christopoulos, A ;
Lanzafame, A ;
Mitchelson, F .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (3-4) :185-194
[5]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[6]   Uncovering molecular mechanisms involved in activation of G protein-coupled receptors [J].
Gether, U .
ENDOCRINE REVIEWS, 2000, 21 (01) :90-113
[7]   Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors [J].
Gnagey, AL ;
Seidenberg, M ;
Ellis, J .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1245-1253
[8]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[9]   A model of the human M2 muscarinic acetylcholine receptor [J].
Jöhren, K ;
Höltje, HD .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (11) :795-801
[10]   Essential role for the second extracellular loop in C5a receptor activation [J].
Klco, JM ;
Wiegand, CB ;
Narzinski, K ;
Baranski, TJ .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (04) :320-326